Paclitaxel-Coated Devices: How the Process of Ruling Out Safety Concerns Is Improving Vascular Surgery Research
Consult QD
SEPTEMBER 7, 2023
He adds, however, that there’s more hesitancy in community practice, especially in light of the FDA’s initial 2019 guidance to use alternative therapies for most patients. Physicians were told to use these devices only for high-risk lesions in high-risk patients, but ‘high risk’ was never defined,” he explains.
73 
Let's personalize your content